Categories Earnings
Earnings | ALEMBIC PHARMACEUTICALS LIMITED (NSE: APLLTD): Q4FY23 Results Out; Total Income fell 1.3% YoY.
Alembic Pharmaceuticals is an Indian pharmaceutical company that specializes in the development, manufacturing, and marketing of a diverse range of pharmaceutical products, including formulations and active pharmaceutical ingredients. Founded in 1907, the company has a strong focus on research and development, and has invested heavily in state-of-the-art facilities and advanced technologies to deliver high-quality products. Alembic Pharmaceuticals has a wide range of therapeutic products, including medicines for cardiovascular, anti-infective, gastroenterology, and central nervous system disorders, among others.
- ALEMBIC PHARMACEUTICALS LIMITED reported Total Income for Q4 FY23 of ₹1,407 Crore down from ₹1,426 Crore year on year, a negative growth of 1.3%.
- Total Expenses for Q4 FY23 of ₹1,288 Crore down from ₹1,385 Crore year on year, a negative growth of 7%.
- Consolidated Net Profit of ₹152 Crore, up 590% from ₹22 Crore in the same quarter of the previous year.
- The Earnings per Share is ₹7.76, up 599% from ₹1.11 in the same quarter of the previous year.
Most Popular
Cochin Shipyard Ltd (COCHINSHIP) Q4 FY22 Earnings Concall Transcript
Cochin Shipyard Limited (NSE:COCHINSHIP) Q4 FY22 Earnings Concall dated May. 26, 2022 Corporate Participants: Madhu S Nair -- Chairman & Managing Director Jose V J -- Director Finance Analysts: Vastupal Shah
All you need to know about Antony Waste Handling Cell in one article
Can you guess the name of the company that was listed during the IPO frenzy in 2020 and is the second largest player in the Indian municipal waste management industry?
Demystifying the Leading Non-Ferrous Recycling Company of India
“Hey, how is the market doing today?” “Oh!, its falling tremendously since morning” I am sure news like these might be a common topic of discussion for you nowadays. Interestingly,